相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hierarchical graph representations in digital pathology
Pushpak Pati et al.
MEDICAL IMAGE ANALYSIS (2022)
Digital pathology and artificial intelligence will be key to supporting clinical and academic cellular pathology through COVID-19 and future crises: the PathLAKE consortium perspective
Lisa Browning et al.
JOURNAL OF CLINICAL PATHOLOGY (2021)
Deep neural network models for computational histopathology: A survey
Chetan L. Srinidhi et al.
MEDICAL IMAGE ANALYSIS (2021)
Pathologist Concordance for Ovarian Carcinoma Subtype Classification and Identification of Relevant Histologic Features Using Microscope and Whole Slide Imaging A Multisite Observer Study
Marios A. Gavrielides et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2021)
The human-in-the-loop: an evaluation of pathologists' interaction with artificial intelligence in clinical practice
Anna C. S. Boden et al.
HISTOPATHOLOGY (2021)
Hidden Variables in Deep Learning Digital Pathology and Their Potential to Cause Batch Effects: Prediction Model Study
Max Schmitt et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2021)
Deep learning in histopathology: the path to the clinic
Jeroen van der Laak et al.
NATURE MEDICINE (2021)
Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence
Gary S. Collins et al.
BMJ OPEN (2021)
Multi-institutional TSA-amplified Multiplexed Immunofluorescence Reproducibility Evaluation (MITRE) Study
Janis M. Taube et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Complete Digital Pathology for Routine Histopathology Diagnosis in a Multicenter Hospital Network
Juan Antonio Retamero et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2020)
PD-L1 expression in gastric cancer determined by digital image analyses: pitfalls and correlation with pathologist interpretation
Han-Na Kim et al.
VIRCHOWS ARCHIV (2020)
Deep Learning Based on Standard H&E Images of Primary Melanoma Tumors Identifies Patients at Risk for Visceral Recurrence and Death
Prathamesh M. Kulkarni et al.
CLINICAL CANCER RESEARCH (2020)
The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation
Janis M. Taube et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Predicting treatment response to neoadjuvant chemoradiotherapy in local advanced rectal cancer by biopsy digital pathology image features
Fang Zhang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Classification and mutation prediction based on histopathology H&E images in liver cancer using deep learning
Mingyu Chen et al.
NPJ PRECISION ONCOLOGY (2020)
Digital pathology and computational image analysis in nephropathology
Laura Barisoni et al.
NATURE REVIEWS NEPHROLOGY (2020)
Tumor purity as a prognosis and immunotherapy relevant feature in gastric cancer
Zhe Gong et al.
CANCER MEDICINE (2020)
Clinical Trials for Artificial Intelligence in Cancer Diagnosis: A Cross-Sectional Study of Registered Trials inClinicalTrials.gov
Jingsi Dong et al.
FRONTIERS IN ONCOLOGY (2020)
Association of digital and manual quantification of tumor PD-L1 expression with outcomes in nivolumab-treated patients
Chunzhe Duan et al.
CANCER RESEARCH (2020)
Introduction to digital pathology and computer-aided pathology
Soojeong Nam et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2020)
A Practical Guide to Whole Slide Imaging A White Paper From the Digital Pathology Association
Mark D. Zarella et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2019)
Whole slide imaging equivalency and efficiency study: experience at a large academic center
Matthew G. Hanna et al.
MODERN PATHOLOGY (2019)
Epithelium segmentation using deep learning in H&E-stained prostate specimens with immunohistochemistry as reference standard
Wouter Bulten et al.
SCIENTIFIC REPORTS (2019)
CD8+T cells in tumor parenchyma and stroma by image analysis (IA) and gene expression profiling (GEP): Potential biomarkers for immuno-oncology (I-O) therapy.
Peter M. Szabo et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Applications of machine learning in drug discovery and development
Jessica Vamathevan et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Automated image analysis of NSCLC biopsies to predict response to anti-PD-L1 therapy
Sonja Althammer et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Preanalytic Variables and Tissue Stewardship for Reliable Next-Generation Sequencing (NGS) Clinical Analysis
Paolo A. Ascierto et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2019)
Computational pathology definitions, best practices, and recommendations for regulatory guidance: a white paper from the Digital Pathology Association
Esther Abels et al.
JOURNAL OF PATHOLOGY (2019)
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
Jakob Nikolas Kather et al.
NATURE MEDICINE (2019)
Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta-analysis
Steve Lu et al.
JAMA ONCOLOGY (2019)
Deep learning outperformed 11 pathologists in the classification of histopathological melanoma images
Achim Hekler et al.
EUROPEAN JOURNAL OF CANCER (2019)
Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology
Kaustav Bera et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
LAG3: The Biological Processes That Motivate Targeting This Immune Checkpoint Molecule in Human Cancer
Cinzia Solinas et al.
CANCERS (2019)
2021PQuantitative spatial profiling of lymphocyte-activation gene 3 (LAG-3)/major histocompatibility complex class II (MHC II) interaction in gastric and urothelial tumors
C V Hedvat et al.
ANNALS OF ONCOLOGY (2019)
Deep learning-based classification of mesothelioma improves prediction of patient outcome
Pierre Courtiol et al.
NATURE MEDICINE (2019)
Quantitative Image Analysis of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry for Breast Cancer
Marilyn M. Bui et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2019)
Precision immunoprofiling by image analysis and artificial intelligence
Viktor H. Koelzer et al.
VIRCHOWS ARCHIV (2019)
Quantitative Characterization of CD8+ T Cell Clustering and Spatial Heterogeneity in Solid Tumors
Chang Gong et al.
FRONTIERS IN ONCOLOGY (2019)
Translational AI and Deep Learning in Diagnostic Pathology
Ahmed Serag et al.
FRONTIERS IN MEDICINE (2019)
The use of digital pathology and image analysis in clinical trials
Robert Pell et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2019)
Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast Cancer
Gil Shamai et al.
JAMA NETWORK OPEN (2019)
Histo-genomics: digital pathology at the forefront of precision medicine
Ivraym Barsoum et al.
DIAGNOSIS (2019)
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)
T. R. Cottrell et al.
ANNALS OF ONCOLOGY (2018)
PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project
Ming Sound Tsao et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pages et al.
LANCET (2018)
Noninvasive detection of macrophage activation with single-cell resolution through machine learning
Nicolas Pavillon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Not Just Digital Pathology, Intelligent Digital Pathology
Balazs Acs et al.
JAMA ONCOLOGY (2018)
Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis
Keith E. Steele et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Computer-extracted features relating to spatial arrangement of tumor infiltrating lymphocytes to predict response to nivolumab in non-small cell lung cancer (NSCLC).
Cristian Barrera et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Computer extracted features of cancer nuclei from H&E stained tissues of tumor predicts response to nivolumab in non-small cell lung cancer.
Xiangxue Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
Yelena Y. Janjigian et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
Roger Sun et al.
LANCET ONCOLOGY (2018)
Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning
Nicolas Coudray et al.
NATURE MEDICINE (2018)
Prognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New Evidences
Xinyu Yan et al.
FRONTIERS IN PHARMACOLOGY (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Deciphering the immune microenvironment of a tissue by digital imaging and cognition network
A. Lopes et al.
SCIENTIFIC REPORTS (2018)
CD4 and CD8 T lymphocyte interplay in controlling tumor growth
Dmitrij Ostroumov et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Continuous measurement of breast tumour hormone receptor expression: a comparison of two computational pathology platforms
Thomas P. Ahern et al.
JOURNAL OF CLINICAL PATHOLOGY (2017)
Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer
Babak Ehteshami Bejnordi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer
Reinhard Buttner et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
Leora Horn et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer et al.
LANCET (2017)
Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial
James L. Gulley et al.
LANCET ONCOLOGY (2017)
PD-L1 immunohistochemistry in clinical diagnostics of lung cancer: inter-pathologist variability is higher than assay variability
Hans Brunnstrom et al.
MODERN PATHOLOGY (2017)
Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer
Laurence Buisseret et al.
MODERN PATHOLOGY (2017)
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
D. P. Carbone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
J. Bellmunt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
Julienne L. Carstens et al.
NATURE COMMUNICATIONS (2017)
Benchmarking of Whole Exome Sequencing and Ad Hoc Designed Panels for Genetic Testing of Hereditary Cancer
Lidia Feliubadalo et al.
SCIENTIFIC REPORTS (2017)
Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC
Paul C. Tumeh et al.
CANCER IMMUNOLOGY RESEARCH (2017)
A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer
David L. Rimm et al.
JAMA ONCOLOGY (2017)
Classification of breast cancer histology images using Convolutional Neural Networks
Teresa Araujo et al.
PLOS ONE (2017)
Relevance of deep learning to facilitate the diagnosis of HER2 status in breast cancer
Michel E. Vandenberghe et al.
SCIENTIFIC REPORTS (2017)
Accurate and reproducible invasive breast cancer detection in whole-slide images: A Deep Learning approach for quantifying tumor extent
Angel Cruz-Roa et al.
SCIENTIFIC REPORTS (2017)
Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis
Sami Blom et al.
SCIENTIFIC REPORTS (2017)
Diagnostic Immunohistochemistry What Can Go Wrong and How to Prevent It
Allen M. Gown
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated with neoadjuvant-adjuvant trastuzumab after 2 years of treatment-free follow-up
Christian Jackisch et al.
EUROPEAN JOURNAL OF CANCER (2016)
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
Louis Fehrenbacher et al.
LANCET (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al.
LANCET (2016)
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
Corey J. Langer et al.
LANCET ONCOLOGY (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
International Clinical Guidelines for the Adoption of Digital Pathology: A Review of Technical Aspects
Marcia Garcia-Rojo
PATHOBIOLOGY (2016)
Comprehensive Immunohistochemistry: Digital, Analytical and Integrated
Arvydas Laurinavicius et al.
PATHOBIOLOGY (2016)
Novel technologies and emerging biomarkers for personalized cancer immunotherapy
Jianda Yuan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Recent developments in multiplexing techniques for immunohistochemistry
Angela R. Dixon et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)
Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathology
Andreas Heindl et al.
LABORATORY INVESTIGATION (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
Zipei Feng et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Dynamics of Allograft Fibrosis in Pediatric Liver Transplantation
C. Venturi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Pathology is a necessary and informative tool in oncology clinical trials
Iris D. Nagtegaal et al.
JOURNAL OF PATHOLOGY (2014)
Pathology in drug discovery and development
Adrian M. Jubb et al.
JOURNAL OF PATHOLOGY (2014)
Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
Brian D. Lehmann et al.
JOURNAL OF PATHOLOGY (2014)
The estimation of tumor cell percentage for molecular testing by pathologists is not accurate
Alexander J. J. Smits et al.
MODERN PATHOLOGY (2014)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)
Automated Image Analysis Method for Detecting and Quantifying Macrovesicular Steatosis in Hematoxylin and Eosin-Stained Histology Images of Human Livers
Nir I. Nativ et al.
LIVER TRANSPLANTATION (2014)
Multiplexed immunohistochemistry, imaging, and quantitation: A review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis
Edward C. Stack et al.
METHODS (2014)
Digital pathology and image analysis in tissue biomarker research
Peter W. Hamilton et al.
METHODS (2014)
Central Pathology Review for Phase III Clinical Trials
Pawel Mroz et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2013)
Validating Whole Slide Imaging for Diagnostic Purposes in Pathology Guideline from the College of American Pathologists Pathology and Laboratory Quality Center
Liron Pantanowitz et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2013)
Scientific and Regulatory Policy Committee (SRPC) Paper: Validation of Digital Pathology Systems in the Regulated Nonclinical Environment
Richard E. Long et al.
TOXICOLOGIC PATHOLOGY (2013)
Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer
S. T. Martin et al.
BRITISH JOURNAL OF SURGERY (2012)
Digital Pathology and Image Analysis for Robust High-Throughput Quantitative Assessment of Alzheimer Disease Neuropathologic Changes
Janna Hackett Neltner et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue
Steven J. Potts et al.
LABORATORY INVESTIGATION (2012)
Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival
Andrew H. Beck et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Interobserver Variability in Histologic Evaluation of Radical Prostatectomy Between Central and Local Pathologists: Findings of TAX 3501 Multinational Clinical Trial
George J. Netto et al.
UROLOGY (2011)
Computerized Histologic Image-Based Risk Score (IbRiS) Classifier for ER+ Breast Cancer.
S. Ganesan et al.
CANCER RESEARCH (2010)
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
Monique Maas et al.
LANCET ONCOLOGY (2010)
Digital pathology in drug discovery and development: multisite integration
Steven J. Potts
DRUG DISCOVERY TODAY (2009)
High efficacy of pre-operative trastuzumab combined with paclitaxel following doxorubicin cyclophosphamide in operable breast cancer
Shani Paluch-Shimon et al.
ACTA ONCOLOGICA (2008)
The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates
Jeffrey A. Kramer et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
Qiang Gao et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
分享论文
